» Articles » PMID: 24767549

Exhaled Breath Profiling for Diagnosing Acute Respiratory Distress Syndrome

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2014 Apr 29
PMID 24767549
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The acute respiratory distress syndrome (ARDS) is a common, devastating complication of critical illness that is characterized by pulmonary injury and inflammation. The clinical diagnosis may be improved by means of objective biological markers. Electronic nose (eNose) technology can rapidly and non-invasively provide breath prints, which are profiles of volatile metabolites in the exhaled breath. We hypothesized that breath prints could facilitate accurate diagnosis of ARDS in intubated and ventilated intensive care unit (ICU) patients.

Methods: Prospective single-center cohort study with training and temporal external validation cohort. Breath of newly intubated and mechanically ventilated ICU-patients was analyzed using an electronic nose within 24 hours after admission. ARDS was diagnosed and classified by the Berlin clinical consensus definition. The eNose was trained to recognize ARDS in a training cohort and the diagnostic performance was evaluated in a temporal external validation cohort.

Results: In the training cohort (40 patients with ARDS versus 66 controls) the diagnostic model for ARDS showed a moderate discrimination, with an area under the receiver-operator characteristic curve (AUC-ROC) of 0.72 (95%-confidence interval (CI): 0.63-0.82). In the external validation cohort (18 patients with ARDS versus 26 controls) the AUC-ROC was 0.71 [95%-CI: 0.54 - 0.87]. Restricting discrimination to patients with moderate or severe ARDS versus controls resulted in an AUC-ROC of 0.80 [95%-CI: 0.70 - 0.90]. The exhaled breath profile from patients with cardiopulmonary edema and pneumonia was different from that of patients with moderate/severe ARDS.

Conclusions: An electronic nose can rapidly and non-invasively discriminate between patients with and without ARDS with modest accuracy. Diagnostic accuracy increased when only moderate and severe ARDS patients were considered. This implicates that breath analysis may allow for rapid, bedside detection of ARDS, especially if our findings are reproduced using continuous exhaled breath profiling.

Trial Registration: NTR2750, registered 11 February 2011.

Citing Articles

Exhaled Volatile Organic Compounds Detection in Pneumonia Screening: A Comprehensive Meta-analysis.

He J, Zhong R, Xue L, Wang Y, Chen Y, Xiong Z Lung. 2024; 202(5):501-511.

PMID: 39180684 PMC: 11427597. DOI: 10.1007/s00408-024-00737-8.


Breath metabolomics for diagnosis of acute respiratory distress syndrome.

Zhang S, Hagens L, Heijnen N, Smit M, Brinkman P, Fenn D Crit Care. 2024; 28(1):96.

PMID: 38521944 PMC: 10960461. DOI: 10.1186/s13054-024-04882-7.


Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant.

Sharma R, Zang W, Tabartehfarahani A, Lam A, Huang X, Devi Sivakumar A JAMA Netw Open. 2023; 6(2):e230982.

PMID: 36853606 PMC: 9975913. DOI: 10.1001/jamanetworkopen.2023.0982.


Exhaled Biomarkers for Point-of-Care Diagnosis: Recent Advances and New Challenges in Breathomics.

Kiss H, Orlos Z, Gellert A, Megyesfalvi Z, Mikaczo A, Sarkozi A Micromachines (Basel). 2023; 14(2).

PMID: 36838091 PMC: 9964519. DOI: 10.3390/mi14020391.


Breath analysis for detection and trajectory monitoring of acute respiratory distress syndrome in swine.

Sharma R, Zhou M, Tiba M, McCracken B, Dickson R, Gillies C ERJ Open Res. 2022; 8(1).

PMID: 35174248 PMC: 8841990. DOI: 10.1183/23120541.00154-2021.


References
1.
Bowler R, Duda B, Chan E, Enghild J, Ware L, Matthay M . Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004; 286(6):L1095-104. DOI: 10.1152/ajplung.00304.2003. View

2.
Schubert J, Muller W, Benzing A, Geiger K . Application of a new method for analysis of exhaled gas in critically ill patients. Intensive Care Med. 1998; 24(5):415-21. DOI: 10.1007/s001340050589. View

3.
Agrawal A, Matthay M, Kangelaris K, Stein J, Chu J, Imp B . Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med. 2013; 187(7):736-42. PMC: 3678110. DOI: 10.1164/rccm.201208-1460OC. View

4.
Friedrich M . Scientists seek to sniff out diseases: electronic "noses" may someday be diagnostic tools. JAMA. 2009; 301(6):585-6. DOI: 10.1001/jama.2009.90. View

5.
Fens N, Roldaan A, van der Schee M, Boksem R, Zwinderman A, Bel E . External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin Exp Allergy. 2011; 41(10):1371-8. DOI: 10.1111/j.1365-2222.2011.03800.x. View